In an unusual development, the United Kingdom today reported a second monkeypox case just 3 days after announcing its first case, but so far the investigation doesn't show a link between the two patients, Public Health England (PHE) said today in a statement.
The United Kingdom's National Institute for Health and Care Excellence (NICE) today issued draft guidance for the treatment of urinary tract infections (UTIs).
In response to cholera outbreaks in several African countries over the past several months, the World Health Organization (WHO) today announced the largest cholera vaccination drive in history, with a goal of reaching 2 million people.
Rain, war, and other factors have helped create the largest cholera outbreak in history, researchers say.
A 2-year follow-up study of the single-dose oral cholera vaccine (OCV) showed it was effective in adults and children over the age of 5 years. Consistent with results from the 6-month follow-up, the vaccine failed to protect children under the age of 5 from the disease.
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, today weighed in on steps the FDA it taking to improve the effectiveness of seasonal flu vaccines, which includes collaborating with partners at the Centers for Medicare and Medicaid Services (CMS) to use a large database that includes information on flu vaccines given to 4 million people.
In a joint statement today the World Health Organization (WHO) and South Korean health officials issued public health recommendations for people attending the upcoming winter Olympic and Paralympic Games in Pyeongchang.
A growing number of vaccine makers are expressing concerns about their ability to quickly develop new vaccine candidates against emerging disease threat, such as Zika and Ebola viruses, Stat reported today, based on interviews with pharmaceutical executives, government officials, and infectious disease experts.
The Saudi Arabian Ministry of Health (MOH) announced a new case of MERS-CoV in Taif today.
A 45-year-old Saudi woman is in stable condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection. Her source of infection is listed as "primary," meaning it's unlikely she contracted the virus from another person. She is not a healthcare worker.
SIGA Technologies of New York City announced yesterday that it has submitted its smallpox drug TPOXX (tecovirimat) for priority review by the US Food and Drug Administration (FDA).
